Trial · NCT07908238
Maximising Maternal Milk for Preterm Infant
NCT07908238, Not applicable, Recruiting, National Maternity Hospital, Ireland
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Maximising Maternal Milk for Preterm Infant. Trials, record NCT07908238. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07908238
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Maximising Maternal Milk for Preterm Infant
- NCT number
- NCT07908238
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 160 participants, estimated
- Lead sponsor
- National Maternity Hospital, Ireland
- Conditions
- Breastfeeding, Prematurity
- Interventions
- Hospital grade double electrical breast milk pump
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of women achieving > 500mls expressed breast milk by 14 days' post-partum | from enrolment to two weeks post delivery | |
| Primary | Percentage of women achieving > 500mls by 14 days' post-partum in mothers of preterm infants < 33 weeks gestation and/or 1500 gram | Milk amount from time of enrolment to two weeks post delivery | Mothers of preterm infants \<33 weeks and /or 1500 gram will randomly assigned to early breast pumping group or late breast pumping group as outlined above , the primary outcome is the achieving of more than 500 ml of breast milk by day 14 post delivery. |
| Secondary | Parenteral nutrition days | From the time of enrolment until 6 weeks post menstrual age | Total days of parenteral nutrition until reaching to full feed |
| Secondary | Time to full feeds | From date of randomization until reaching fullfeed | How many days required to reach full feed |
| Secondary | Donor milk use | From the time of enrolment until 6 weeks post menstrual age | The number of participants who required donor milk from birth until discharge |
| Secondary | Central line associated blood stream infections | From the time of enrolment until 6 weeks post menstrual age | The number of participants with any documented central line infection from birth until discharge from hospital .Catheter-related bloodstream infection Clinical signs of sepsis and positive peripheral blood culture in the absence of an obvious source other than CVC with one of the following: Positive semiquantitative (\>15 CFU) or quantitative (\>103 CFU) culture from a part of the catheter with the same organisms isolated peripherally Simultaneous quantitative blood cultures with a ratio of ≥3:1 (CVC vs. peripheral) Time difference of ≤2 hours leading to culture positive between CVC and peripheral cultures. Central line-associated bloodstream infection is primary bloodstream infection in a patient who had a central line within the 48 hours period before development of infection. |
| Secondary | Necrotising enterocolitis | From the time of enrolment until 6 weeks post menstrual age | The number of participants who had any episode of necrotizing enterocolitis as defined by Modified Bell's staging criteria from enrolment to discharge. |
| Secondary | Chronic lung disease | From the time of enrolment until 6 weeks post menstrual age | Total numbers of days of respiratory support for the participant |
| Secondary | Late onset sepsis | From the time of enrolment until 6 weeks post menstrual age | The number of participants who had any documented late onset sepsis, described as documented infection after 72 hours after birth . |
| Secondary | Breastfeeding at hospital discharge | From the time of enrolment until 6 weeks post menstrual age | The number of participants involved in the study discharged home on breast feeding |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07908238
GET https://conductscience.org/api/trials/v1/NCT07908238/registered